Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kenvue Inc (KVUE)

Kenvue Inc (KVUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 34,736,788
  • Shares Outstanding, K 1,915,984
  • Annual Sales, $ 15,455 M
  • Annual Income, $ 1,030 M
  • EBIT $ 2,362 M
  • EBITDA $ 2,984 M
  • 60-Month Beta 0.59
  • Price/Sales 2.33
  • Price/Cash Flow 12.28
  • Price/Book 3.26

Options Overview Details

View History
  • Implied Volatility 35.65% (+3.47%)
  • Historical Volatility 17.73%
  • IV Percentile 52%
  • IV Rank 25.99%
  • IV High 92.41% on 12/03/25
  • IV Low 15.71% on 05/28/25
  • Expected Move (DTE 5) 0.43 (2.39%)
  • Put/Call Vol Ratio 0.19
  • Today's Volume 13,351
  • Volume Avg (30-Day) 17,795
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 722,368
  • Open Int (30-Day) 837,300
  • Expected Range 17.70 to 18.56

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.22
  • Number of Estimates 3
  • High Estimate 0.23
  • Low Estimate 0.21
  • Prior Year 0.26
  • Growth Rate Est. (year over year) -15.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.56 +9.51%
on 01/07/26
18.22 -0.49%
on 02/05/26
+1.38 (+8.24%)
since 01/06/26
3-Month
15.94 +13.74%
on 11/17/25
18.22 -0.49%
on 02/05/26
+1.67 (+10.15%)
since 11/06/25
52-Week
14.02 +29.32%
on 10/30/25
25.17 -27.97%
on 05/08/25
-1.67 (-8.43%)
since 02/06/25

Most Recent Stories

More News
Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026

Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2025 financial results after market close on February 17, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not...

KVUE : 18.13 (+0.33%)
1 Dividend King to Buy and Hold Through Any Market

In uncertain markets, reliable income matters more than ever. This Dividend King offers exactly that.

$SPX : 6,932.30 (+1.97%)
JNJ : 239.99 (+0.93%)
KVUE : 18.13 (+0.33%)
Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue

Key Milestone in Creating a Global Health and Wellness Leader

KMB : 104.33 (+0.07%)
KVUE : 18.13 (+0.33%)
Kenvue Is Headed for a Merger Vote on January 29. How Should You Play KVUE Stock Here?

KVUE stock could gain 15% this week if the potential merger with Kimberly-Clark is approved by all major stakeholders.

KMB : 104.33 (+0.07%)
JNJ : 239.99 (+0.93%)
KVUE : 18.13 (+0.33%)
Kenvue Stock: Analyst Estimates & Ratings

As Kenvue has underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.

KMB : 104.33 (+0.07%)
$SPX : 6,932.30 (+1.97%)
KVUE : 18.13 (+0.33%)
XLP : 87.94 (+1.17%)
Kenvue Declares Quarterly Cash Dividend

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on February 25, 2026, to shareholders...

KVUE : 18.13 (+0.33%)
Earnings Preview: What to Expect From Kenvue’s Report

Kenvue is gearing to release its fourth-quarter results shortly, and analysts expect its earnings to fall in low-double-digits.

KMB : 104.33 (+0.07%)
$SPX : 6,932.30 (+1.97%)
JNJ : 239.99 (+0.93%)
KVUE : 18.13 (+0.33%)
XLP : 87.94 (+1.17%)
Halper Sadeh LLC Encourages FRGE, EXAS, CIVI, KVUE Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm as there may be limited time to enforce your rights.  

EXAS : 103.18 (+0.51%)
CIVI : 27.38 (-1.37%)
KVUE : 18.13 (+0.33%)
FRGE : 44.65 (+0.02%)
Kenvue Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE

NEW YORK and NEW ORLEANS , Jan. 7, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC ("KSF") are investigating the...

KMB : 104.33 (+0.07%)
KVUE : 18.13 (+0.33%)
Bullseye Bounce: Toms Capital Takes a Stake in Target

The entry of activist investor Toms Capital, coupled with a discounted valuation, signals strong potential for a turnaround for the retailer in the coming year.

TGT : 115.55 (+4.24%)
KMB : 104.33 (+0.07%)
KVUE : 18.13 (+0.33%)
K : 83.44 (-0.01%)
WMT : 131.18 (+3.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J.

See More

Key Turning Points

3rd Resistance Point 18.36
2nd Resistance Point 18.27
1st Resistance Point 18.20
Last Price 18.13
1st Support Level 18.04
2nd Support Level 17.95
3rd Support Level 17.88

See More

52-Week High 25.17
Fibonacci 61.8% 20.91
Fibonacci 50% 19.60
Fibonacci 38.2% 18.28
Last Price 18.13
52-Week Low 14.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar